The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Pfizer Independent Grants for Learning & Change Request for Proposals (RFP) Pfizer and British Medical Journal – Developing Clinical Research and Publication Skills
The mission of the British Medical Journal (The BMJ) is to publish rigorous, accessible, and entertaining material that will help doctors and medical students in their daily practice, lifelong learning, and career development. As well as publishing research, BMJ (in collaboration with the University of San Francisco California (USFC)) has developed the “Research to Publication programme” which is part of BMJ's commitment to building medical research capabilities around the world. Research to Publication is a gold standard online programme of self-study courses to enable doctors and healthcare researchers to develop clinical research skills, write the best possible papers, and succeed in getting papers published.
The mission of Pfizer Independent Grants for Learning & Change (IGLC) is to partner with the global healthcare community to improve patient outcomes in areas of mutual interest through support of measurable learning and change strategies. “Independent” means that the projects funded by Pfizer are the full responsibility of the recipient organisation. Pfizer has no influence over any aspect of the projects and only asks for reports about the results and the impact of the projects in order to share them publicly.
Research to Publication is a gold standard online programme of self-study courses to enable doctors and healthcare researchers to develop clinical research skills, write the best possible papers, and succeed in getting papers published. For more information on what the programme entails and how your institution may benefit from access, visit rtop.bmj.com.
Pfizer and the BMJ invite academic and healthcare organisations organisations with an interest in conducting clinical research, epidemiological/public health research and/or health services research to apply for provision of access to Research to Publication with the purpose of improving the conduct of, and publication rate for, clinical research in the targeted nations (see “Geographic Scope” section of this RFP). Please note that Research to Publication is not intended to support researchers improve basic science research skills.
It is expected that all applications will include a needs assessment detailing why access to the programme would benefit the applying organisation, and also an implementation plan detailing how the training will be utilised and disseminated.
Whilst applications will be accepted from all countries listed in the Geographic Scope section of this document, priority will be given to applications from organisations based in lower income countries (according to the World Bank Classifications). Priority will also be given to applications from organisations higher income countries where it can be demonstrated that there is local need for support that might not be reflected by the country’s income status. Priority will further be given to applications from organisations with the most robust implementation plans.
Application Deadline: 17:00 GMT on 30th April 2018
Geographic Scope: International (specify country/countries): All countries according in Europe, Africa and The Middle East.
Applicant Eligibility Criteria: The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); academic institutions and other entities with a mission related to healthcare improvement.
Individual applications requesting institution access for up to; 50, 100, 150, 200, 250 Research to Publication programme users and then over 250 Research to Publication programme users will be considered. The funding required for provision of access for users’ increases with the number of users included within the application, and as such, it is important that the projected outcomes of the application are appropriately associated with the application number of programme users requested. The total available budget related to this RFP is £50,000, however, please note that no funds will be transferred to the organisations to whom access to Research to Publication is awarded. Access will be purchased on behalf of the successful organisations by Pfizer, and access granted by the BMJ.